The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study.

Kidney Int Rep · 2017 · PMC5678679 · PMID 29142984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

This adjustment revealed a nonsignificant trend toward a better CV survival profile in patients who took RAS blockers (ACEI or ARB) compared with patients who started therapy with a ß-blocker at the end of follow-up ( Figure 3 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.